Recent News (2)

CEO Brent Lucas Discusses Regulation, Innovation, and the Road to Fully Implantable Hearing Devices On “This Week in Hearing”, with Hearing Health Advocate and author Shari Eberts

Feb 17, 2025 11:59:34 PM

**Envoy Medical (NASDAQ: COCH) — Could This Be the Stock to Revolutionize Hearing Forever?

Jan 7, 2025 12:30:00 AM

Envoy Medical Names Seven Investigational Sites for Participation in Its Pivotal Clinical Study

Dec 19, 2024 8:44:15 AM

Initial patient enrollment anticipated during first quarter of 2025 White Bear Lake, Minnesota--(New...

Advancing Hearing Health with Implantable Devices

Dec 19, 2024 2:45:00 AM

The Empowered Patient Podcast: Advancing Hearing Health with Implantable Devices. Featuring Brent Lu...

Envoy Medical Receives Additional Patent Protection for its Innovative Approach to Hearing Loss

Dec 16, 2024 11:09:09 AM

WHITE BEAR LAKE, Minnesota , Dec. 16, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”...

Envoy Medical CEO Brent Lucas Returns to the Big Biz Show

Dec 9, 2024 3:53:06 PM

Envoy Medical Reports Third Quarter 2024 Results and Other Exciting Events

Nov 14, 2024 11:36:36 AM

FDA approval to begin pivotal trial of fully implanted cochlear implant and AMA approval of CPT code...

Envoy Medical’s Fully Implanted Acclaim® Cochlear Implant Highlighted in Peer-Reviewed Publication

Nov 12, 2024 9:27:20 AM

Study in Otology & Neurotology outlines early experiences and potential benefits of breakthrough...

Envoy Medical Receives Another European Patent for its Modular Cochlear Implant System

Nov 8, 2024 9:28:24 AM

WHITE BEAR LAKE, Minnesota, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”)...

Envoy Medical Receives FDA Approval to Initiate Pivotal Clinical Study for Breakthrough Hearing Device

Nov 1, 2024 8:48:58 AM

The Acclaim® Fully Implanted Cochlear Implant is differentiated from existing cochlear implants and ...

*The materials and resources presented are intended to be an educational resource for general purposes only. They are not intended to constitute medical or business advice or in any way replace the independent medical judgment of a trained and licensed physician. Each person’s situation is unique and risks, outcomes, experience and results may vary. CAUTION: The fully implanted Acclaim Cochlear Implant is an investigational device. Limited by federal (or United States) law to investigational use.

**See Important Information here.

News Room

CEO Brent Lucas Discusses Regulation, Innovation, and the Road to Fully Implantable Hearing Devices On “This Week in Hearing”, with Hearing Health Advocate and author Shari Eberts

**Envoy Medical (NASDAQ: COCH) — Could This Be the Stock to Revolutionize Hearing Forever?

Envoy Medical Names Seven Investigational Sites for Participation in Its Pivotal Clinical Study

Advancing Hearing Health with Implantable Devices

Envoy Medical Receives Additional Patent Protection for its Innovative Approach to Hearing Loss

Envoy Medical CEO Brent Lucas Returns to the Big Biz Show

Envoy Medical Reports Third Quarter 2024 Results and Other Exciting Events

Envoy Medical’s Fully Implanted Acclaim® Cochlear Implant Highlighted in Peer-Reviewed Publication

Envoy Medical Receives Another European Patent for its Modular Cochlear Implant System

Envoy Medical Receives FDA Approval to Initiate Pivotal Clinical Study for Breakthrough Hearing Device

Be the first to know!
Subscribe to news updates.

Sounding Board

The Changing Landscape of Hearing Accessibility

Hearing Health and Earth Day: More Connections than You Might Think

Empowering the Experts: World Hearing Day 2025

Solutions

Company

Legal